• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Dr. Reddy's Laboratories Ltd. (RDY)

    -NYSE
    50.47 Down 3.53(6.54%) Jan 30, 4:04PM EST
    |After Hours : 50.45 Down 0.02 (0.04%) Jan 30, 4:20PM EST
    Add to Portfolio
    Prev Close:54.00
    Open:52.11
    Bid:50.00 x 500
    Ask:50.72 x 100
    1y Target Est:54.45
    Beta:1.23
    Next Earnings Date:N/A
    Day's Range:50.02 - 52.22
    52wk Range:38.23 - 59.02
    Volume:584,921
    Avg Vol (3m):279,387
    Market Cap:8.60B
    P/E (ttm):23.81
    EPS (ttm):2.12
    Div & Yield:0.28 (0.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RDY

    Comparison

    Symbol% ChgMkt Cap
    RDYDown 6.54%8.60B
    TEVADown 1.22%48.60B

    Key Statistics

    Forward P/E (1 yr):23.15
    P/S (ttm):4.03
    Ex-Dividend Date:01-Aug-14

    Analysts

    Annual EPS Est (Mar-14) :N/A
    Quarterly EPS Est (Mar-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company in India. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback